𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient

✍ Scribed by Kazuhide Tsuji; Toshitada Hamada; Akiko Uenaka; Hisashi Wada; Eiichi Sato; Midori Isobe; Kenji Asagoe; Osamu Yamasaki; Hiroshi Shiku; Gerd Ritter; Roger Murphy; Eric W. Hoffman; Lloyd J. Old; Eiichi Nakayama; Keiji Iwatsuki

Book ID
105967400
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
475 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody response against NY-ESO-1 in CH
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
✍ Ryohei Kawabata; Hisashi Wada; Midori Isobe; Takashi Saika; Shuichiro Sato; Akik 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB

## Abstract NY‐ESO‐1 specific humoral responses are frequently observed in patients with various types of NY‐ESO‐1 antigen expressing tumors. In a large proportion of NY‐ESO‐1 antibody‐positive patients of NY‐ESO‐1‐specific CD8 T‐cells can also be detected suggesting that monitoring of the NY‐ESO‐1

Humoral immune responses of cancer patie
Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events
✍ Elke Jäger; Elisabeth Stockert; Zacharias Zidianakis; Yao-Tseng Chen; Julia Karb 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 165 KB 👁 2 views

Humoral immune responses against the ''Cancer-Testis'' (CT) antigen NY-ESO-1 are frequently observed in patients with NY-ESO-1 expressing tumors. This is in contrast to other known tumor antigens (TA) defined by antibody or cytotoxic T cell (CTL) reactivity, i.e., MAGE-1, MAGE-3, SSX2, Melan A, and